HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Open accessThe DOI matches its Crossref record; 53 of the 56 references it cites were found in a registry or an index.
Abstract
Myeloid-derived suppressor cells (MDSCs) are a major component of the immune-suppressive network described in cancer and many other pathological conditions. We demonstrate that although MDSCs from peripheral lymphoid organs and the tumor site share similar phenotype and morphology, these cells display profound functional differences. MDSC from peripheral lymphoid organs suppressed antigen-specific CD8+ T cells but failed to inhibit nonspecific T cell function. In sharp contrast, tumor MDSC suppressed both antigen-specific and nonspecific T cell activity. The tumor microenvironment caused rapid and dramatic up-regulation of arginase I and inducible nitric oxide synthase in MDSC, which was accompanied by down-regulation of nicotinamide adenine dinucleotide phosphate–oxidase and reactive oxygen species in these cells. In contrast to MDSC from the spleen, MDSC from the tumor site rapidly differentiated into macrophages. Exposure of spleen MDSC to hypoxia resulted in the conversion of these cells to nonspecific suppressors and their preferential differentiation to macrophages. Hypoxia-inducible factor (HIF) 1α was found to be primarily responsible for the observed effects of the tumor microenvironment on MDSC differentiation and function. Thus, hypoxia via HIF-1α dramatically alters the function of MDSC in the tumor microenvironment and redirects their differentiation toward tumor-associated macrophages, hence providing a mechanistic link between different myeloid suppressive cells in the tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypoxia can abolish the cell killing activity of NK cells, which correlates with an increase in HIF-1α [78].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“tumor hypoxia generates macrophages that can suppress T cell responses. This suppressive phenotype is mediated by hypoxic induction of arginase 1 and nitric oxide synthase, both that restrict T cell activation. Strikingly, induction of this hypoxic pathway in macrophages is required for optimal tumor growth [84, 85].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [85]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the mesothelioma microenvironment, the availability of glucose is critical, and competition for this molecule impacts on T-cell function and the recruitment of immune infiltrating cells, promoting angiogenesis [119,120,121,122].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [119]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, tumor hypoxia and/or HIFs can attract myeloid-derived suppressor cells (Corzo et al., 2010), regulatory T-cells (Clambey et al., 2012), and tumor-associated macrophages (Doedens et al., 2010;Imtiyaz et al., 2010) with immunosuppressive functions.”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Corzo et al., 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which suggests that 32-134D inhibited the expression of these latter mRNAs in immune or other stromal cell types, where HIFs are known to play critical roles (56–61), rather than in tumor cells.”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [56]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775 · cited 2×
“Extensive studies in recent years suggested several mechanisms of MDSC-mediated immune suppression that involve arginine (Bronte and Zanovello, 2005; Rodríguez and Ochoa, 2008) and cysteine (Srivastava et al., 2010) metabolism, expression of some surface molecules (Pan et al., 2010), up-regulation…”
BackgroundMyeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Self-citationSubsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Self-citationAlmand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Self-citationMovahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
Cited by
Items 701–800 of 1,000
Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment
Wei, J., Hu, M., & Du, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845923 · Cited by 34
Alvear-Arias, J. J., Carrillo-Soto, C. A., Villar, J., García-Betancourt, R., Peña-Pichicoi, A., Fernández, A., Fernández, M., Carmona, E. M., Pupo, A., Neely, A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104453119 · Cited by 29
Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances
Derenzini, E., & Younes, A. (2011) · Genome Medicine · doi:10.1186/gm240 · Cited by 30
Tuo, Y., Zhang, Z., Tian, C., Hu, Q.-Y., Xie, R., Yang, J., Zhou, H. W., Lu, L., & Xiang, M. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma0120-578r · Cited by 26
Self-citationChen, Z.-X., Mu, M.-Y., Yang, G., Qi, H., Fu, X., Wang, G., Jiang, W., Huang, B., & Gao, F. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07089-4 · Cited by 29
Huang, Y., & Fang, W. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01152-9 · Cited by 34
Al‐Taei, S., Banner, R., Powell, N. G., Evans, M., Palaniappan, N., Tabi, Z., & Man, S. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1488-5 · Cited by 24
Defective TGF-b Signaling in Bone Marrow-Derived Cells Prevents Hedgehog-Induced Skin Tumors
Fan, Q., Gu, D., Liu, H., Yang, L., Zhang, X., Yöder, M. C., Kaplan, M. H., & Xie, J. (2013) · PMC · Cited by 24
Schröder, M., Krötschel, M., Conrad, L., Naumann, S. K., Bachran, C., Rolfe, A., Umansky, V., Helming, L., & Swee, L. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-31674-1 · Cited by 26
Venkatesh, G. H., Khouzam, R. A., El‐Sayed, W., Zeinelabdin, N. A., Terry, S., & Chouaïb, S. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1974233 · Cited by 25
Gao, H., Yao, Y., Li, W., Xu, Z., Hu, W., Luo, K.-W., Chen, P., Shang, W., Luan, S., Shi, G., et al. (2025) · Advanced Science · doi:10.1002/advs.202411375 · Cited by 32
Pro-tumoral functions of tumor-associated macrophage EV-miRNA
Cocks, A., Vecchio, F. D., Martinez‐Rodriguez, V., Schukking, M., & Fabbri, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.08.001 · Cited by 28
Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors
Alvarez, R., Mandal, D., & Chittiboina, P. (2021) · Cells · doi:10.3390/cells10112913 · Cited by 27
Duarte‐Sanmiguel, S., Salazar‐Puerta, A. I., Panic, A., Dodd, D. J., Francis, C., Alzate‐Correa, D., Ortega‐Pineda, L., Lemmerman, L. R., Rincon‐Benavides, M. A., Dathathreya, K., et al. (2023) · Biomaterials Science · doi:10.1039/d3bm00573a · Cited by 26
Ambrosini, G., Cordani, M., Zarrabi, A., Alcón-Rodríguez, S., Sainz, R. M., Velasco, G., González‐Menéndez, P., & Dando, I. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01462-0 · Cited by 28
Wang, W., Fan, J., Zhang, C., Huang, Y., Chen, Y., Fu, S., & Wu, J. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127668 · Cited by 25
Anti-tumor immunity: Myeloid leukocytes control the immune landscape
Rutkowski, M. R., Stephen, T. L., & Conejo-Garcia, J. R. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.06.014 · Cited by 28
Metabolomic profiling of tumor-infiltrating macrophages during tumor growth
Umemura, N., Sugimoto, M., Kitoh, Y., Saio, M., & Sakagami, H. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02622-8 · Cited by 23
Resheq, Y. J., Li, K., Ward, S., Wilhelm, A., Garg, A., Curbishley, S. M., Blahova, M., Zimmermann, H. W., Jitschin, R., Mougiakakos, D., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401046 · Cited by 23
Zhang, W., Jin, C., Liu, S., Wan, X., Li, Y., Liu, J., Duan, Z., Ma, J., & Gao, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1757513 · Cited by 22
Zhao, S., Zhou, L., Dicker, D. T., Lev, A., Zhang, S., Ross, E. A., & El‐Deiry, W. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-00150-8 · Cited by 23
Jarman, E. J., Horcas‐Lopez, M., Waddell, S. H., MacMaster, S., Gournopanos, K., Soong, D. Y. H., Musialik, K. I., Tsokkou, P., Ng, M.-E., Cambridge, W. A., et al. (2022) · Liver International · doi:10.1111/liv.15383 · Cited by 22
Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy
Zaher, A., Stephens, L. M., Miller, A. M., Hartwig, S. M., Stolwijk, J. M., Petronek, M. S., Zacharias, Z. R., Wadas, T. J., Monga, V., Cullen, J. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.989000 · Cited by 26
Sankar, K. N., Pearson, A. N., Worlikar, T., Perricone, M. D., Holcomb, E. A., Mendiratta‐Lala, M., Xu, Z., Bhowmick, N. A., & Green, M. D. (2023) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-23-11 · Cited by 22
Oishi, K., Sakaguchi, T., Baba, S., Suzuki, S., & Konno, H. (2014) · Surgery Today · doi:10.1007/s00595-014-0989-y · Cited by 22
Diao, J., Zhao, J., Winter, E., & Cattral, M. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004125 · Cited by 22
Hong, H.-J., Lim, H. X., Song, J. H., Lee, A., Kim, E., Cho, D., Cohen, E. P., & Kim, T. S. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1777-2 · Cited by 22
Animal Models and the Tumor Microenvironment: Studies of Tumor–Host Symbiosis
Lindner, D. J. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.004 · Cited by 25
Pogoda, K., Pyszniak, M., Rybojad, P., & Tabarkiewicz, J. (2016) · Oncology Letters · doi:10.3892/ol.2016.5273 · Cited by 27
Myeloid-derived suppressor cells (MDSC): Another player in the orchestra
Gimeno, R., & Barquinero, J. (2011) · Inmunología · doi:10.1016/s0213-9626(11)70015-4 · Cited by 26
Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment
Hameed, S., Bhattarai, P., & Dai, Z. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9256-1 · Cited by 21
Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment
Fan, Y., Wang, Y., Zhang, J., Dong, X., Gao, P., Liu, K., Ma, C., & Zhao, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746621 · Cited by 26
Pereira, M., Matuszewska, K., Jamieson, C., & Petrik, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.772349 · Cited by 23
Anderson, K. G., Braun, D. A., Buqué, A., Gitto, S. B., Guerriero, J. L., Horton, B. L., Keenan, B. P., Kim, T. S., Overacre-Delgoffe, A. E., Ruella, M., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006533 · Cited by 24
Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression
Nóbrega, A. H. L., Pimentel, R. S., do Prado, A. P. S., Garcia, J., Frozza, R. L., & Bernardi, A. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096265849231031101449 · Cited by 25
Hypoxia, Hypoxia-Inducible Factor-1α, and Innate Antileishmanial Immune Responses
Schatz, V., Neubert, P., Rieger, F., & Jantsch, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00216 · Cited by 25
The tumour microenvironment links complement system dysregulation and hypoxic signalling
Olcina, M. M., Kim, R. K., Melemenidis, S., Graves, E. E., & Giaccia, A. J. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180069 · Cited by 23
Pilátová, K., Bencsiková, B., Demlová, R., Valík, D., & Dubská, L. Z. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2166-4 · Cited by 21
Connections between Metabolism and Epigenetic Modification in MDSCs
Dai, H., Xu, H., Wang, S., & Ma, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197356 · Cited by 23
Deronic, A., Tahvili, S., Leanderson, T., & Ivars, F. (2016) · BMC Cancer · doi:10.1186/s12885-016-2481-0 · Cited by 21
Ramesh, R. P. G., Yasmin, H., Ponnachan, P., al-Ramadi, B. K., Kishore, U., & Joseph, A. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1573522 · Cited by 22
Polyamines regulate adaptive antitumor immunity by functional specialization of regulatory T cells
Bündgen, G., Ulges, A., Pietruschka, J., Truong-Andrievici, N., Klein, M., Romaniuk, K., Schmitt, F., Hagen, M., Seebass, J. G., Zezlina, L., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.007 · Cited by 24
Lei, X., Zheng, B., Peng, Y., Zhang, G., Cheng, X., Li, W., He, J., Li, F., Ling, R., Fu, Z., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.113325 · Cited by 21
Monitoring of the Immune Dysfunction in Cancer Patients
Santegoets, S. J. A. M., Welters, M. J. P., & van der Burg, S. (2016) · Vaccines · doi:10.3390/vaccines4030029 · Cited by 23
Role of hyperoxic treatment in cancer
Kim, S. W., Kim, I. K., & Lee, S. H. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220921547 · Cited by 22
Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease
Salminen, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104919 · Cited by 25
Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS
Velegraki, M., Stiff, A. R., Papadaki, H. Α., & Li, Z. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164908 · Cited by 21
The role of the natural killer (NK) cell modulation in breast cancer incidence and progress
Razeghian, E., Kameh, M. C., Shafiee, S., Khalafi, F., Jafari, F., Asghari, M., Kazemi, K., Ilkhani, S., Shariatzadeh, S., & Haj‐Mirzaian, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07865-5 · Cited by 23
Design of Nanoparticles in Cancer Therapy Based on Tumor Microenvironment Properties
Firouzabadi, B. M., Gigliobianco, M. R., Joseph, J. M., Censi, R., & Martino, P. D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122708 · Cited by 22
Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
Zhang, W., Lyu, P., Andreev, D., Jia, Y., Zhang, F., & Bözec, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.974851 · Cited by 22
PEITC treatment suppresses myeloid derived tumor suppressor cells to inhibit breast tumor growth
Gupta, P., Wright, S. E., & Srivastava, S. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.981449 · Cited by 20
Stromal-dependent tumor promotion by MIF family members
Mitchell, R. A., & Yaddanapudi, K. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.09.012 · Cited by 24
Immune modulation by genetic modification of dendritic cells with lentiviral vectors
Liechtenstein, T., Pérez‐Janices, N., Bricogne, C., Lanna, A., Dufait, I., Goyvaerts, C., Laranga, R., Padella, A., Vargas, F. A., Baratchian, M., et al. (2013) · Virus Research · doi:10.1016/j.virusres.2013.05.007 · Cited by 24
Plavc, G., & Strojan, P. (2020) · Radiology and Oncology · doi:10.2478/raon-2020-0060 · Cited by 23
Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers
King, R., Hayes, C., Donohoe, C. L., Dunne, M. R., Davern, M., & Donlon, N. E. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i5.312 · Cited by 25
Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer
Mussa, A., Ismail, N. H., Hamid, M., Al-Hatamleh, M. A. I., Bragoli, A. J., Hajissa, K., Mokhtar, N. F., Mohamud, R., Uskoković, V., & Hassan, R. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03218-1 · Cited by 24
Wen, K., Yan, Y., Shi, J., Hu, L., Wang, W., Liao, H., Li, H., Zhu, Y., Mao, K., & Xiao, Z. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.809672 · Cited by 23
Principe, N., Aston, W. J., Hope, D. E., Tilsed, C. M., Fisher, S. A., Boon, L., Dick, I. M., Chin, W. L., McDonnell, A. M., Nowak, A. K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.872295 · Cited by 22
Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine
Cao, Q., Mertens, R. T., Sivanathan, K. N., Cai, X., & Xiao, P. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0322-176r · Cited by 21
Cutaneous Tumors Cease CXCL9/Mig Production as a Result of IFN-γ–Mediated Immunoediting
Petro, M., Kish, D. D., Guryanova, O. A., Ilyinskaya, G. V., Kondratova, A. A., Fairchild, R. L., & Gorbachev, A. V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201906 · Cited by 20
Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment
Xiong, J., Wang, H., & Wang, Q. (2021) · Advanced Biology · doi:10.1002/adbi.201900311 · Cited by 21
Han, E. C., Lee, J., Ryu, S., & Choi, C. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.117 · Cited by 19
Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy
Liu, L., Wu, D., Qian, Z., Ying, J., You, Y., Wang, Y., Zhang, F., Ning, X., Mei, J., Iqbal, J., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02682-8 · Cited by 23
Tumor-related stress regulates functional plasticity of MDSCs
Mandula, J. K., & Rodríguez, P. C. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104312 · Cited by 18
Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105186 · Cited by 20
Capietto, A.-H., Lee, S., Clever, D. C., Eul, E. M., Ellis, H., Ma, C. X., & Faccio, R. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0232 · Cited by 21
Nitrogen-Doped Carbon Nanotube Cups for Cancer Therapy
Burkert, S. C., He, X., Shurin, G. V., Nefedova, Y., Kagan, V. E., Shurin, M. R., & Star, A. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c03245 · Cited by 18
Tumour microenvironment and heterotypic interactions in pancreatic cancer
Velasco, R. M., García, A. G., Sánchez, P. J., Sellart, I. M., & Lobo, V. J. S.-A. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00875-8 · Cited by 19
Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis
Jou, E., Rodríguez‐Rodríguez, N., & McKenzie, A. N. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.981479 · Cited by 19
Zhang, W., Li, X., Jiang, M., Ji, C., Chen, G., Zhang, Q., Liu, P., Zhang, R., Ren, X., Yu, W., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad020 · Cited by 20
Wang, C., Fei, K., Liu, L., Duan, J., Wang, Z., Li, S., Xu, J., Zhang, X., Tian, Y., Qu, Y., et al. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.14929 · Cited by 21
L’hypoxie tumorale: Un déterminant clé de la réactivité stromale et de la réponse antitumorale
Hasmim, M., Messai, Y., Noman, M. Z., & Chouaïb, S. (2014) · médecine/sciences · doi:10.1051/medsci/20143004017 · Cited by 21
Wang, J., Zhang, Y., Yin, K., Xu, P., Tian, J., Ma, J., Tian, X., Wang, Y., Tang, X., Xu, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13978 · Cited by 18
Nachmany, I., Bogoch, Y., Sivan, A., Amar, O., Bondar, E., Zohar, N., Yakubovsky, O., Fainaru, O., Klausner, J. M., & Pencovich, N. (2019) · The FASEB Journal · doi:10.1096/fj.201801733r · Cited by 22
Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
Bokas, A., Papakotoulas, P., Sarantis, P., Papadimitropoulou, A., Papavassiliou, A. G., & Karamouzis, M. V. (2020) · Cancers · doi:10.3390/cancers12020432 · Cited by 19
Fernández, A., Oliver, L., Álvarez-Arzola, R., Hernández, A., Raymond, J., Fernandez, L. E., & Mesa, C. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-5 · Cited by 20
Herrera-Campos, A. B., Zamudio-Martinez, E., Delgado-Bellido, D., Fernández-Cortés, M., Montuenga, L. M., Oliver, F. J., & Garcia-Diaz, A. (2022) · Cancers · doi:10.3390/cancers14112740 · Cited by 17
Jiang, X., Wu, A., Yan, J., Chen, J., Wen, Y., Wu, H., Yan, N., Yang, Z., Liu, F., & Li, P. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114907 · Cited by 19
Enabling CAR-T cells for solid tumors: Rage against the suppressive tumor microenvironment
Antoñana-Vildosola, A., Zanetti, S. R., & Palazón, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.03.004 · Cited by 18
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment
Stavrou, V., Fultang, L., Booth, S., Simone, D. D., Bartnik, A., Scarpa, U., Gneo, L., Panetti, S., Potluri, S., Almowaled, M., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03268-4 · Cited by 18
Self-citationCombining EZH2 inhibitors with other therapies for solid tumors: more choices for better effects
Huang, R., Wu, Y., & Zou, Z. (2022) · Epigenomics · doi:10.2217/epi-2022-0320 · Cited by 19
Liu, Z., Geng, Y., Huang, Y., Hu, R., Li, F., Ding, J., Ma, W., Dong, H., Song, K., Xu, X., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155164 · Cited by 17
Engineering metabolism to modulate immunity
Kapnick, S. M., Martin, C. A., & Jewell, C. M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115122 · Cited by 19
Maggs, L., & Ferrone, S. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0358 · Cited by 20
Choi, J. U., Lee, N. K., Seo, H., Chung, S. W., Al-Hilal, T. A., Park, S. J., Kweon, S., Min, N., Kim, S. K., Ahn, S.-H., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002332 · Cited by 18
The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis
Bayık, D., Lee, J., & Lathia, J. D. (2022) · Experientia supplementum · doi:10.1007/978-3-030-91311-3_7 · Cited by 20
Xiang, S., Zhan, H., Zhan, J., Li, X., Lin, X., & Sun, W. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100400 · Cited by 57
Mechanisms of HIF-driven immunosuppression in tumour microenvironment
Bandopadhyay, S., & Patranabis, S. (2023) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-023-00186-z · Cited by 25
Schröder, M., Loos, S., Naumann, S. K., Bachran, C., Krötschel, M., Umansky, V., Helming, L., & Swee, L. K. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1258503 · Cited by 18
Jia, A., Wang, Y., Wang, Y., Li, Y., Yang, Q., Cao, Y., He, Y., Lin, D., Dong, Y., Hou, Y., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00610-7 · Cited by 16
Tsilimigras, D. I., Ntanasis‐Stathopoulos, I., Moris, D., & Pawlik, T. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_14 · Cited by 17
Increased hypoxia-inducible factor 1alpha expression in rat brain tissues in response to aging.
Wang, H., Wu, H., Guo, H., Zhang, G., Zhang, R., & Zhan, S. (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.10.010 · Cited by 21
Serine/threonine-protein kinase 24 is an inhibitor of gastric cancer metastasisPreprint
Chen, Y., Wang, C., Fang, J.-H., & Hsu, H. (2021) · Research Square · doi:10.21203/rs.3.rs-217140/v1 · Cited by 15
O’Connor, M. A., Vella, J. L., & Green, W. R. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000260 · Cited by 16
Wang, Q., Zhang, X., Li, C., Xiong, M., Bai, W., Sun, S., Chen, C., Zhang, X., Li, M., & Zhao, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868669 · Cited by 17
c-Rel-dependent monocytes are potent immune suppressor cells in cancer
Li, T., Bou-Dargham, M. J., Fultang, N., Li, X., Pear, W. S., Sun, H., & Chen, Y. H. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ma0422-518rr · Cited by 15
Schwarz, J., Rühle, J., Stephan, K., Dietz, S., Geißert, J., Schoppmeier, U., Frick, J.-S., Hudalla, H., Lajqi, T., Poets, C. F., et al. (2023) · European Journal of Immunology · doi:10.1002/eji.202250144 · Cited by 16
Li, L., Ma, S., & Yu, Z. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00881-y · Cited by 17
Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies
Zeng, Y., Gao, Y., He, L., Ge, W., Wang, X., Ma, T., & Xie, X.-Y. (2024) · Nanoscale Advances · doi:10.1039/d4na00285g · Cited by 16
Su, M., Xu, X., Wei, W., Gao, S., Wang, X., Chen, C., & Zhang, Y. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0327-0 · Cited by 15
Metadata
- Authors
- Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., & Gabrilovich, D. I.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Gabrilovich, Dmitry I.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-09-27
- Volume
- 207
- Issue
- 11
- Pages
- 2439-2453
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2964584
- OpenAlex
- W2109424201
- Semantic Scholar
- 77cf3cf3976e026979d2b7acf9b04119740a45f1
- Cited by
- 1,173
- References
- 56
- Citations by year
- 2026: 69 · 2025: 73 · 2024: 69 · 2023: 92 · 2022: 80 · 2021: 109 · 2020: 93 · 2019: 62 · 2018: 83 · 2017: 62 · 2016: 69 · 2015: 51 · 2014: 70 · 2013: 76 · 2012: 61
- FWCI
- 25.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Moffitt Cancer Center
- National Institutes of Health
- National Cancer Institute (CA84488, R01CA084488, R01CA103921, R01CA136828, R01CA100062)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- myeloid-derived suppressor cells, HIF-1α, tumor microenvironment, hypoxia, tumor-associated macrophages, T cell suppression, arginase-1, inducible nitric oxide synthase, NADPH oxidase, reactive oxygen species, MDSC differentiation, immunosuppression
- MeSH terms
- Aged, Animals, Antigens, Neoplasm, Arginase, Cell Differentiation, Female, Humans, Macrophages, Male, Mice, Inbred BALB C, Middle Aged, Neoplasms, Cell Hypoxia, CD8-Positive T-Lymphocytes, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.